Your Patients Trust You. Now You Can Trust Their Results.

Introducing a technology solution specifically designed in collaboration with children's hospitals to reduce blood culture contamination and the risks associated with false-positive sepsis test results.

The Clinical Impact of Blood Culture Contamination

Every blood culture contamination event exposes patients to unnecessary safety risks such as prolonged use of toxic broad-spectrum antibiotics and associated C. difficile infections, multidrug-resistant organism infections and other antibiotic related complications, longer hospital stays and increased readmissions. On average each contamination event at a children’s hospital costs an average of $8,720 with additional potential loss of CMS/Medicaid revenue due to CDI and false-positive CLABSIs.^1-3

To combat blood culture contamination rates, hospitals rely on education and training. Yet the problem is not the clinician drawing the blood culture but the process. During venipuncture, skin fragments containing viable microorganisms are often dislodged and collected within the initial specimen often causing the patient to test false-positive for a serious bloodstream infection. For blood culture contamination rates to approach zero, a technology platform that is designed to actively divert and sequester the initial volume of blood is needed.

Meet Micro

With Steripath® Micro, you can consistently divert and sequester the skin contaminants known to cause false-positive blood culture results. The latest, low-volume Initial Specimen Diversion Device^® provides you with a reliable contamination-reducing technology for better patient outcomes and decreased cost burdens from a sepsis misdiagnosis.

Designed in collaboration with children’s hospitals nationwide

FDA-cleared and indicated to reduce blood culture contamination.⁴

Requires less than 1mL of blood for patients with limited volumes or difficult intravenous access

Fast, easy, user-controlled draws with preassembled integrated syringe configurations

Our Promise to You, Your Patients and Your Hospital

Easy integration into current workflows

Improved patient experience and outcomes

Sustained hospital cost savings

Collect Blood Cultures, with Confidence.

The Steripath^® Micro Blood Culture Collection System includes a 7” CT-compatible Luer extension set and is available in multiple integrated syringe sizes.

Thank you! We will be in contact with you shortly. In the meantime, please visit magnolia-medical.com to learn more about Steripath^®.

All the best,
Magnolia Medical

We're sorry. An error occurred during the submission of this form. Please try submitting the form again.

References:

1. Gander RM, Byrd L, DeCrescenzo M, Hirany S, Bowen M, Baughman J. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol. 2009;47(4):1021–1024pmid:19171686

2. Garcia RA, Spitzer ED, Beaudry J, et al. Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line-associated bloodstream infections. Am J Infect Control. 2015;43(11):1222–1237pmid:26298636.

3. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA. 1991;265(3):365–369pmid:1984535

4. Indicated for use as a blood collection system that diverts and sequesters the initial specimen prior to collection of a subsequent test sample to reduce the frequency of blood culture contamination when contaminants are present in the initial blood sample compared to blood cultures drawn with standard procedure without manual diversion